Fas ligand–mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas (original) (raw)

• Schneider, C., Pasqualucci, L. & Dalla-Favera, R. Molecular pathogenesis of diffuse large B-cell lymphoma. Semin. Diagn. Pathol. 28, 167–177 (2011).
  PubMed PubMed Central Google Scholar
• Nogai, H., Dorken, B. & Lenz, G. Pathogenesis of non-Hodgkin's lymphoma. J. Clin. Oncol. 29, 1803–1811 (2011).
  CAS PubMed Google Scholar
• Rosenwald, A. et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med. 198, 851–862 (2003).
  CAS PubMed PubMed Central Google Scholar
• Frick, M., Dorken, B. & Lenz, G. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma. Best Pract. Res. Clin. Haematol. 25, 3–12 (2012).
  CAS PubMed Google Scholar
• Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).
  CAS PubMed Google Scholar
• Lenz, G. & Staudt, L.M. Aggressive lymphomas. N. Engl. J. Med. 362, 1417–1429 (2010).
  CAS PubMed Google Scholar
• Rui, L., Schmitz, R., Ceribelli, M. & Staudt, L.M. Malignant pirates of the immune system. Nat. Immunol. 12, 933–940 (2011).
  CAS PubMed Google Scholar
• Shapiro-Shelef, M. et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19, 607–620 (2003).
  CAS PubMed Google Scholar
• Kallies, A. et al. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity 26, 555–566 (2007).
  CAS PubMed Google Scholar
• Mandelbaum, J. et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell–like diffuse large B cell lymphoma. Cancer Cell 18, 568–579 (2010).
  CAS PubMed PubMed Central Google Scholar
• Calado, D.P. et al. Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell–like diffuse large cell lymphoma. Cancer Cell 18, 580–589 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ye, B.H. et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262, 747–750 (1993).
  CAS PubMed Google Scholar
• Iqbal, J. et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 21, 2332–2343 (2007).
  CAS PubMed PubMed Central Google Scholar
• Dent, A.L., Shaffer, A.L., Yu, X., Allman, D. & Staudt, L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276, 589–592 (1997).
  CAS PubMed Google Scholar
• Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553–563 (2000).
  CAS PubMed Google Scholar
• Pasqualucci, L. et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 95, 11816–11821 (1998).
  CAS PubMed Google Scholar
• Shen, H.M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750–1752 (1998).
  CAS PubMed Google Scholar
• Yamane, A. et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 12, 62–69 (2011).
  CAS PubMed Google Scholar
• Cattoretti, G. et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 7, 445–455 (2005).
  CAS PubMed Google Scholar
• Grulich, A.E., van Leeuwen, M.T., Falster, M.O. & Vajdic, C.M. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370, 59–67 (2007).
  PubMed Google Scholar
• Schreiber, R.D., Old, L.J. & Smyth, M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).
  CAS PubMed Google Scholar
• Challa-Malladi, M. et al. Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20, 728–740 (2011).
  CAS PubMed PubMed Central Google Scholar
• Rimsza, L.M. et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103, 4251–4258 (2004).
  CAS PubMed Google Scholar
• Smyth, M.J. et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755–760 (2000).
  CAS PubMed PubMed Central Google Scholar
• Street, S.E. et al. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells. J. Exp. Med. 199, 879–884 (2004).
  CAS PubMed PubMed Central Google Scholar
• Kallies, A. et al. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200, 967–977 (2004).
  CAS PubMed PubMed Central Google Scholar
• Kutok, J.L. & Wang, F. Spectrum of Epstein-Barr virus–associated diseases. Annu. Rev. Pathol. 1, 375–404 (2006).
  CAS PubMed Google Scholar
• Lee, K.S., Groshong, S.D., Cool, C.D., Kleinschmidt-DeMasters, B.K. & van Dyk, L.F. Murine gammaherpesvirus 68 infection of IFNγ unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease. Cancer Res. 69, 5481–5489 (2009).
  CAS PubMed PubMed Central Google Scholar
• D'Costa, K. et al. Blimp1 is limiting for transformation in a mouse plasmacytoma model. Blood 113, 5911–5919 (2009).
  CAS PubMed Google Scholar
• Pasqualucci, L. et al. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 40, 108–112 (2008).
  CAS PubMed Google Scholar
• Stopeck, A.T. et al. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin. Cancer Res. 6, 3904–3909 (2000).
  CAS PubMed Google Scholar
• Salek-Ardakani, S. et al. B cell–specific expression of B7–2 is required for follicular TH cell function in response to vaccinia virus. J. Immunol. 186, 5294–5303 (2011).
  CAS PubMed PubMed Central Google Scholar
• Victora, G.D. et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143, 592–605 (2010).
  CAS PubMed PubMed Central Google Scholar
• Man, K. et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14, 1155–1165 (2013).
  CAS PubMed Google Scholar
• Kaech, S.M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749–761 (2012).
  CAS PubMed PubMed Central Google Scholar
• Burnet, F.M. The concept of immunological surveillance. Prog. Exp. Tumor Res. 13, 1–27 (1970).
  CAS PubMed Google Scholar
• Willimsky, G. & Blankenstein, T. The adaptive immune response to sporadic cancer. Immunol. Rev. 220, 102–112 (2007).
  CAS PubMed Google Scholar
• Zhang, B. et al. Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell 148, 739–751 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Expression of the AID protein in normal and neoplastic B cells. Blood 104, 3318–3325 (2004).
  CAS PubMed Google Scholar
• Kitano, M. et al. Bcl6 protein expression shapes pre–germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 34, 961–972 (2011).
  CAS PubMed Google Scholar
• Kolar, G.R., Mehta, D., Pelayo, R. & Capra, J.D. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood 109, 2545–2552 (2007).
  CAS PubMed PubMed Central Google Scholar
• Marshall, J.L. et al. Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts. Eur. J. Immunol. 41, 3506–3512 (2011).
  CAS PubMed Google Scholar
• Kaji, T. et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J. Exp. Med. 209, 2079–2097 (2012).
  CAS PubMed PubMed Central Google Scholar
• Rosenberg, S.A., Restifo, N.P., Yang, J.C., Morgan, R.A. & Dudley, M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8, 299–308 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bolitho, P. et al. Perforin-mediated suppression of B-cell lymphoma. Proc. Natl. Acad. Sci. USA 106, 2723–2728 (2009).
  CAS PubMed Google Scholar
• Koebel, C.M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903–907 (2007).
  CAS PubMed Google Scholar
• Davidson, W.F., Giese, T. & Fredrickson, T.N. Spontaneous development of plasmacytoid tumors in mice with defective Fas–Fas ligand interactions. J. Exp. Med. 187, 1825–1838 (1998).
  CAS PubMed PubMed Central Google Scholar
• Stel, A.J. et al. Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J. Immunol. 178, 2287–2295 (2007).
  CAS PubMed Google Scholar
• Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43, 830–837 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lohr, J.G. et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl. Acad. Sci. USA 109, 3879–3884 (2012).
  CAS PubMed Google Scholar
• Straus, S.E. et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98, 194–200 (2001).
  CAS PubMed Google Scholar
• Müschen, M., Rajewsky, K., Kronke, M. & Kuppers, R. The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol. 23, 75–80 (2002).
  PubMed Google Scholar
• Kojima, Y. et al. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome. Eur. J. Haematol. 76, 465–472 (2006).
  CAS PubMed Google Scholar
• Wang, S.S. et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-κB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE 4, e5360 (2009).
  PubMed PubMed Central Google Scholar
• Harris, J. et al. Cellular (FLICE) like inhibitory protein (cFLIP) expression in diffuse large B-cell lymphoma identifies a poor prognostic subset, but fails to predict the molecular subtype. Hematol. Oncol. 30, 8–12 (2012).
  CAS PubMed Google Scholar
• Novac, N., Baus, D., Dostert, A. & Heinzel, T. Competition between glucocorticoid receptor and NFκB for control of the human FasL promoter. FASEB J. 20, 1074–1081 (2006).
  CAS PubMed Google Scholar
• Esser, M.T., Krishnamurthy, B. & Braciale, V.L. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity. J. Exp. Med. 183, 1697–1706 (1996).
  CAS PubMed Google Scholar
• Kessler, B. et al. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production. J. Immunol. 161, 6939–6946 (1998).
  CAS PubMed Google Scholar
• He, J.S., Gong, D.E. & Ostergaard, H.L. Stored Fas ligand, a mediator of rapid CTL-mediated killing, has a lower threshold for response than degranulation or newly synthesized Fas ligand. J. Immunol. 184, 555–563 (2010).
  CAS PubMed Google Scholar
• Shanker, A. et al. Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity. Cancer Res. 69, 6615–6623 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kallies, A., Xin, A., Belz, G.T. & Nutt, S.L. Blimp-1 transcription factor is required for the differentiation of effector CD8+ T cells and memory responses. Immunity 31, 283–295 (2009).
  CAS PubMed Google Scholar
• Rosenbaum, H. et al. An E μ-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J. 9, 897–905 (1990).
  CAS PubMed PubMed Central Google Scholar
• Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103, 13789–13794 (2006).
  CAS PubMed Google Scholar
• Malissen, M. et al. Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J. 14, 4641–4653 (1995).
  CAS PubMed PubMed Central Google Scholar
• Shahinian, A. et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609–612 (1993).
  CAS PubMed Google Scholar
• Pao, L.I. et al. Functional analysis of granzyme M and its role in immunity to infection. J. Immunol. 175, 3235–3243 (2005).
  CAS PubMed Google Scholar
• Kägi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31–37 (1994).
  PubMed Google Scholar
• Cretney, E. et al. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand–deficient mice. J. Immunol. 168, 1356–1361 (2002).
  CAS PubMed Google Scholar
• Dalton, D.K. et al. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739–1742 (1993).
  CAS PubMed Google Scholar
• O' Reilly, L.A. et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 461, 659–663 (2009).
  CAS PubMed PubMed Central Google Scholar
• Szabo, S.J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338–342 (2002).
  CAS PubMed Google Scholar
• Mittrücker, H.W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540–543 (1997).
  PubMed Google Scholar
• Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17–27 (1994).
  CAS PubMed Google Scholar
• Pridans, C. et al. Identification of Pax5 target genes in early B cell differentiation. J. Immunol. 180, 1719–1728 (2008).
  CAS PubMed Google Scholar
• Kupresanin, F. et al. Dendritic cells present lytic antigens and maintain function throughout persistent gamma-herpesvirus infection. J. Immunol. 179, 7506–7513 (2007).
  CAS PubMed Google Scholar
• Schlissel, M.S., Corcoran, L.M. & Baltimore, D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173, 711–720 (1991).
  CAS PubMed Google Scholar
• Holler, N. et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol. Cell. Biol. 23, 1428–1440 (2003).
  CAS PubMed PubMed Central Google Scholar